Kolinpharma SpA
MIL:KIP

Watchlist Manager
Kolinpharma SpA Logo
Kolinpharma SpA
MIL:KIP
Watchlist
Price: 9.9 EUR Market Closed
Market Cap: 16.2m EUR

Wall Street
Price Targets

KIP Price Targets Summary
Kolinpharma SpA

There are no price targets for KIP.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Kolinpharma SpA Competitors:
Price Targets
200130
KolmarBNH Co Ltd
33% Upside
ICOS
Intercos SpA
53% Upside
HLN
HALEON PLC
16% Upside
300740
SYoung Group Co Ltd
23% Upside
OR
L'Oreal SA
9% Upside
LFMD
LifeMD Inc
136% Upside
4927
Pola Orbis Holdings Inc
2% Upside
BIO
Biome Australia Ltd
137% Upside

Revenue
Forecast

Revenue Estimate
Kolinpharma SpA

For the last 6 years the compound annual growth rate for Kolinpharma SpA's revenue is 33%. The projected CAGR for the next 3 years is 12%.

33%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Kolinpharma SpA

The compound annual growth rate of Kolinpharma SpA's operating income for the next 3 years is 28%.

N/A
Past Growth
28%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Kolinpharma SpA

The compound annual growth rate of Kolinpharma SpA's net income for the next 3 years is 52%.

N/A
Past Growth
52%
Estimated Growth
Estimates Accuracy
-11%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KIP's stock price target?
Not Available

KIP doesn't have any price targets made by Wall Street professionals.

What is Kolinpharma SpA's Revenue forecast?
Projected CAGR
12%

For the last 6 years the compound annual growth rate for Kolinpharma SpA's revenue is 33%. The projected CAGR for the next 3 years is 12%.

What is Kolinpharma SpA's Operating Income forecast?
Projected CAGR
28%

The compound annual growth rate of Kolinpharma SpA's operating income for the next 3 years is 28%.

What is Kolinpharma SpA's Net Income forecast?
Projected CAGR
52%

The compound annual growth rate of Kolinpharma SpA's net income for the next 3 years is 52%.

Back to Top